+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protective effect of oxymatrine on chronic heart failure and ADMA metabolism pathway in isoproterenol-induced chronic heart failure in rats



Protective effect of oxymatrine on chronic heart failure and ADMA metabolism pathway in isoproterenol-induced chronic heart failure in rats



Zhongguo Zhong Yao Za Zhi 39(3): 471-477



To investigate the protective effects of oxymatrine on chronic heart failure induced by isoproterenol (ISO) and to observe its effects on ADMA metabolism pathway in ISO-induced chronic heart failure in rats. Male Sprague-Dawley rats were given oxymatrine (100,50 mg kg-1) orally for 14 days. Heart failure was induced in rats by subcutaneous injection of isoproterenol (5 mg kg-1 d-1 ) at the 8th day for 1 week. Serum parameters, haemodynamic parameters, Heart weight, and histopathological variables were analysed. Expression of protein levels were measured by Western blot. Oxymatrine (100,50 mg kg-1) significantly attenuated serum content of cTn I, improved left ventricle systolic and diastolic function and left ventricular remodeling, reduced the ISO-induced myocardial pathological changes compared with ISO group. In addition, oxymatrine (100,50 mg kg-1) significantly reduced serum level of ADMA (P <0. 01), normalize the reduced dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression (P <0. 01) , but had no effect on the isoproterenol-induced upregulated protein arginine methyltransferases 1 expression. Oxymatrine could ameliorate the experimental ventricular remodeling in ISO-induced chronic heart failure in rats and the mechanism involved in reducing serum content of ADMA and increased DDAH2 expression.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055246180

Download citation: RISBibTeXText

PMID: 24946550


Related references

Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats. European Journal of Pharmacology 745: 29-35, 2015

Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway. Cardiovascular Therapeutics 35(2), 2016

Oxymatrine attenuated isoproterenol-induced heart failure in rats via regulation of COX-2/PGI 2 pathway. Biomedicine and PharmacoTherapy 84: 1359-1366, 2016

Protective effect of oxymatrine on chronic rat heart failure. Journal of Physiological Sciences 61(5): 363-372, 2012

The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats. Drug Development Research 2019, 2019

Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovascular Toxicology 11(1): 48-57, 2011

Heart failure (acute heart failure, chronic heart failure; left ventricular failure, right ventricular failure; systolic heart failure, diastolic heart failure; high output heart failure, low output heart failure). Ryoikibetsu Shokogun Shirizu 1996(12): 107-109, 1996

From neuroendocrine activation to intracardiac cyclic nucleotides in chronic heart failure of rats induced by isoproterenol. Journal Of Chinese Clinical Medicine: 11, 601-608, 2008

Effects of renal denervation on left atrial fibrosis in rats with isoproterenol induced chronic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 43(12): 1040-1045, 2016

Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats. Journal of Cardiovascular Pharmacology and Therapeutics 17(2): 199-207, 2012

Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure. Plos One 13(11): E0206380, 2018

Metabolism of procainamide in patients with chronic heart failure chronic respiratory failure and chronic renal failure. European Journal of Clinical Pharmacology 14(1): 21-28, 1978

Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling. Chinese Medical Journal 115(8): 1166-1169, 2002

Effects of thoracic epidural anesthesia on cardiac function and myocardial cell apoptosis in isoproterenol-induced chronic heart failure rats. Journal of Interventional Cardiology 27(5): 446-455, 2016

Non-invasive prognostic factors in chronic heart failure. One-year survival of 300 patients with a diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy. International Journal of Cardiology 56(3): 283-288, 1996